Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PfSPZ Vaccine Regimen Optimization in Equatorial Guinea
NCT03590340Phase 1Completed
- Sponsor
- Sanaria Inc.
- Start
- Jul 2018
- Primary completion
- Mar 2019
- Modality
- Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
Phase 1, randomised, double-blind trial of Sanaria PfSPZ Vaccine in malaria (8 arms), sponsored by Sanaria Inc. Primary endpoint: Incidence and type of Adverse Events at 1 year. Started Jul 2018; status: completed.
02
Drugs
Sanaria PfSPZ Vaccine
03
Conditions
malaria
Beyond the preview
Go deeper on NCT03590340.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03590340.